Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To evaluate the effects of vitamin E, pioglitazone, sodium-glucose cotransporter-2 (SGLT2) inhibitors, and glucagon-like peptide-1 (GLP-1) receptor agonists in patients with non-alcoholic fatty liver disease (NAFLD). DESIGN: A network meta-analysis. DATA SOURCES: PubMed, Embase, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qian, Wei, Ruojun, Cai, Yuzi, Zhao, Qihan, Liu, Yuning, Liu, Wei Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914474/
https://www.ncbi.nlm.nih.gov/pubmed/35280867
http://dx.doi.org/10.3389/fmed.2022.793203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914474/
https://www.ncbi.nlm.nih.gov/pubmed/35280867
http://dx.doi.org/10.3389/fmed.2022.793203

Ejemplares similares